Lewy bodies, a defining pathological characteristic of Parkinson's disease and dementia with
Lewy bodies (DLB) 1 , 2 , 3 , 4 , constitute the second most common nerve cell pathology, …

Lewy bodies and Lewy neurites are the defining neuropathological characteristics of
Parkinson’s disease and dementia with Lewy bodies. They are made of abnormal filamentous …

Two abundant proteins of 140 and 134 amino acids were purified and sequenced from
human brain. They were identified through their reactivity on immunoblots with a partially …

α-Synuclein forms the major component of Lewy bodies and Lewy neurites, the defining
neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies. Here …

A substantially enriched preparation of Alzheimer paired helical filaments (PHFs) has been
used as a starting point for biochemical studies. Pronase treatment, which strips off adhering …

We have expressed six previously cloned isoforms of human microtubule‐associated tau
protein in Escherichia coli and purified them to homogeneity in a biologically active form. They …

Abnormally phosphorylated tau proteins (A68) are the building blocks of Alzheimer’s disease
(AD) paired helical filaments. The biological consequences of the conversion of normal …

Filamentous inclusions made of α-synuclein constitute the defining neuropathological
characteristic of Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. …

The identification of mutations in the Tau gene in frontotemporal dementia and parkinsonism
linked to chromosome 17 (FTDP-17) has made it possible to express human tau protein …

The presynaptic protein α-synuclein has been implicated in the pathogenesis of Parkinson's
disease. First, two missense mutations A30P and A53T cause inheritable early onset …